BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19959302)

  • 1. [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
    Auboire L; Landy S; Perrot JY; Maïza D; Le Hello C
    J Mal Vasc; 2010 Feb; 35(1):35-7. PubMed ID: 19959302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Raynaud's phenomenon after chemotherapy. Apropos of 3 cases].
    Adoue D; Arlet P; Vilain C; Le Tallec Y; Bonafé JL; de Lafontan B
    Ann Dermatol Venereol; 1985; 112(2):151-5. PubMed ID: 2408534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raynaud's phenomenon - first sign of malignancy: case report].
    Sutić A; Gračanin G; Morović-Vergles J
    Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia nervosa and Raynaud's phenomenon: a case report.
    Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J
    Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital gangrene and Raynaud's phenomenon as complications of lung adenocarcinoma.
    Kopterides P; Tsavaris N; Tzioufas A; Pikazis D; Lazaris A
    Lancet Oncol; 2004 Sep; 5(9):549. PubMed ID: 15337484
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A suspicious reason for Raynaud's phenomenon: Intrauterine device.
    Diken AI; Yalçınkaya A; Aksoy E; Yılmaz S; Çağlı K
    Vascular; 2015 Jun; 23(3):327-8. PubMed ID: 25348785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic Raynaud's phenomenon associated to astrocytoma.
    Bilancini S; Lucchi M; Lucchi G; Carbone I; Bellini D; Polidoro A; Ciacciarelli M
    J Med Vasc; 2020 May; 45(3):161-164. PubMed ID: 32402430
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
    Bellis R; Francès C; Barète S; Senet P
    Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic Raynaud's phenomenon as sign of progression: a case report on a patient with breast cancer.
    Vanlancker T; Stragier B; De Bock M
    Acta Clin Belg; 2022 Feb; 77(1):122-125. PubMed ID: 32578512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. t(8;16) AML developed subsequent to breast cancer therapy.
    Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
    Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
    Di Lauro L; Vici P; Del Medico P; Laudadio L; Tomao S; Giannarelli D; Pizzuti L; Sergi D; Barba M; Maugeri-Saccà M
    Breast Cancer Res Treat; 2013 Aug; 141(1):119-23. PubMed ID: 23982884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
    Leboeuf R; Bénard F; Langlois MF
    Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic Raynaud's phenomenon.
    Taillan B; Castanet J; Garnier G; Pesce A; Sanderson F; Fuzibet JG; Dujardin P
    Clin Rheumatol; 1993 Jun; 12(2):281-2. PubMed ID: 8358996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of severe Raynaud's phenomenon with verapamil.
    Kinney EL; Nicholas GG; Gallo J; Pontoriero C; Zelis R
    J Clin Pharmacol; 1982 Jan; 22(1):74-6. PubMed ID: 7037872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon.
    Lally EV
    Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of Raynaud's phenomenon.
    Nielubowicz J; Zajaç S; Szamowska R; Adamski M
    J Cardiovasc Surg (Torino); 1978; 19(6):607-14. PubMed ID: 739033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's phenomenon].
    Ratner GL; Slutsker GE
    Khirurgiia (Mosk); 1991 Jun; (6):36-40. PubMed ID: 1770734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.